Trial Profile
Modelling study to evaluate the long term serum anti-HAV Ab levels and seroprotection rates, in Argentinean children, after a two-dose vaccination schedule with inactivated hepatitis vaccine (Avaxim)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 13 Feb 2015 New trial record